NCT02112890View on ClinicalTrials.gov

Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in Mexico

CompletedOBSERVATIONAL
Enrollment

1,603

Participants

Timeline

Start Date

December 10, 2014

Primary Completion Date

May 2, 2016

Study Completion Date

May 2, 2016

Conditions
Hepatitis AViral Hepatitis Vaccines
Interventions
OTHER

Data collection

Data of the selected subjects (through structured questionnaires and interviews) and stored serum samples obtained from the ENSANUT 2012. A subset database will be designed by the NIPH for the purpose of this study. Extracted data and laboratory results of the selected subjects will be captured in the study database.

Trial Locations (1)

Unknown

GSK Investigational Site, Cuernavaca

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY